289 related articles for article (PubMed ID: 34882052)
21. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
[TBL] [Abstract][Full Text] [Related]
22. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
Sader HS; Huband MD; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
[No Abstract] [Full Text] [Related]
24. Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
Sonnabend MS; Klein K; Beier S; Angelov A; Kluj R; Mayer C; Groß C; Hofmeister K; Beuttner A; Willmann M; Peter S; Oberhettinger P; Schmidt A; Autenrieth IB; Schütz M; Bohn E
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818817
[TBL] [Abstract][Full Text] [Related]
25. Whole genome sequencing of resistance and virulence genes in multi-drug resistant Pseudomonas aeruginosa.
Almaghrabi RS; Macori G; Sheridan F; McCarthy SC; Floss-Jones A; Fanning S; Althawadi S; Mutabagani M; Binsaslloum A; Alrasheed M; Almohaizeie A; Allehyani B; Alghofaili A; Bohol MF; Al-Qahtani AA
J Infect Public Health; 2024 Feb; 17(2):299-307. PubMed ID: 38154433
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics and Resistance Patterns of Pseudomonas aeruginosa Isolated From Combat Casualties.
Ford MB; Mende K; Kaiser SJ; Beckius ML; Lu D; Stam J; Li P; Stewart L; Tribble DR; Blyth DM
Mil Med; 2022 Mar; 187(3-4):426-434. PubMed ID: 34196358
[TBL] [Abstract][Full Text] [Related]
27. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
[TBL] [Abstract][Full Text] [Related]
29. Genome features and antibiotic resistance of Pseudomonas aeruginosa strains isolated in patients with cystic fibrosis in the Russian Federation.
Bocharova YA; Savinova TA; Lyamin AV; Kondratenko OV; Polikarpova SV; Zhilina SV; Fedorova NI; Semykin SY; Chaplin AV; Korostin DO; Mayansky NA; Chebotar IV
Klin Lab Diagn; 2021 Oct; 66(10):629-634. PubMed ID: 34665950
[TBL] [Abstract][Full Text] [Related]
30. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.
Motbainor H; Bereded F; Mulu W
BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693
[TBL] [Abstract][Full Text] [Related]
31. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.
Slekovec C; Robert J; van der Mee-Marquet N; Berthelot P; Rogues AM; Derouin V; Cholley P; Thouverez M; Hocquet D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):921-926. PubMed ID: 30826996
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region.
Al-Orphaly M; Hadi HA; Eltayeb FK; Al-Hail H; Samuel BG; Sultan AA; Skariah S
mSphere; 2021 May; 6(3):. PubMed ID: 34011686
[TBL] [Abstract][Full Text] [Related]
33. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan.
Sekiguchi J; Asagi T; Miyoshi-Akiyama T; Kasai A; Mizuguchi Y; Araake M; Fujino T; Kikuchi H; Sasaki S; Watari H; Kojima T; Miki H; Kanemitsu K; Kunishima H; Kikuchi Y; Kaku M; Yoshikura H; Kuratsuji T; Kirikae T
J Clin Microbiol; 2007 Mar; 45(3):979-89. PubMed ID: 17122009
[TBL] [Abstract][Full Text] [Related]
34. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
[TBL] [Abstract][Full Text] [Related]
35. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.
Zowawi HM; Syrmis MW; Kidd TJ; Balkhy HH; Walsh TR; Al Johani SM; Al Jindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Sidjabat HE; Baz O; Trembizki E; Whiley DM; Paterson DL
J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716
[TBL] [Abstract][Full Text] [Related]
36. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections.
Haghi F; Zeighami H; Monazami A; Toutouchi F; Nazaralian S; Naderi G
Microb Pathog; 2018 Feb; 115():251-256. PubMed ID: 29273509
[TBL] [Abstract][Full Text] [Related]
37. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals.
Telling K; Laht M; Brauer A; Remm M; Kisand V; Maimets M; Tenson T; Lutsar I
BMC Infect Dis; 2018 Oct; 18(1):513. PubMed ID: 30309321
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of colistin against multidrug-resistant Pseudomonas aeruginosa isolates from patients in Songklanagarind Hospital, Thailand.
Tunyapanit W; Pruekprasert P; Laoprasopwattana K; Chelae S
Southeast Asian J Trop Med Public Health; 2013 Mar; 44(2):273-80. PubMed ID: 23691637
[TBL] [Abstract][Full Text] [Related]
40. Emergence and spread of VIM-type metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates in Japan.
Hishinuma T; Uchida H; Tohya M; Shimojima M; Tada T; Kirikae T
J Glob Antimicrob Resist; 2020 Dec; 23():265-268. PubMed ID: 33045441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
